{"result": {"id": "chatcmpl-531", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "Gastric cancer is a type of cancer that affects the stomach, and it is a major clinical problem leading to significant mortality. It is an aggressive form of cancer that can be life-threatening, often being the leading cause of cancer-related death.  This type of GI cancer is being studied for potential treatments and preventative measures.  It can also be treated with specific combinations like TAS102 plus regorafenib. \n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743328219, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 89, "prompt_tokens": 244, "total_tokens": 333, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"GASTRIC CANCER\"\nDescription List: [\"A leading cause of cancer-related mortality\", \"A major clinical problem\", \"A type of cancer\", \"A type of cancer that affects the stomach\", \"A type of cancer that is aggressive and a leading cause of death from cancer\", \"Specific type of GI cancer being studied\", \"Type of cancer\", \"Type of cancer being treated\", \"Type of cancer that can be prevented by early intervention\", \"Type of cancer that may be treated with the TAS102 plus regorafenib combination\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_9465acafe9363bc8bbb8b750f5942b9d251215d94913092f35ae7ba917884e41_v2"}